Indivior Pharmaceuticals, Inc. (SUPN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $487.00M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $486.00M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $29.00M; Long-term Debt, Excluding Current MaturitiesUSD $290.00M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-Term Debt, Maturity, Year OneUSD $59.00M; Long-Term Debt, Maturity, Year TwoUSD $55.00M.
Indivior Pharmaceuticals, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Borrowings USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $487.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $486.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $29.00M | $290.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $59.00M | $55.00M | $52.00M | $50.00M | $243.00M | $0.00 | (m) |
| 2025-09-30 | $18.00M | $304.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $18.00M | $308.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $18.00M | $311.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $18.00M | $315.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $53.00M | $51.00M | $57.00M | $55.00M | $52.00M | $256.00M | (m) |
| 2023-12-31 | $3.00M | $237.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $311.00M |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $324.00M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $316.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |